Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19-Reference-Cited by-同舟云学术

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19

Published:2021-12 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Shapiro Adrienne E,Bender Ignacio Rachel A

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference9 articles.

1. The RECOVERY platform;Normand;N Engl J Med,2021

2. Repurposed antiviral drugs for COVID-19—interim WHO Solidarity trial results;Pan;N Engl J Med,2021

3. REGN-COV2, a neutralizing antibody cocktail, in outpatients with COVID-19;Weinreich;N Engl J Med,2021

4. Early treatment for COVID-19 with SARS-CoV-2 neutralizing antibody sotrovimab;Gupta;N Engl J Med,2021

5. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial;Lancet Infect Dis,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical technologies assessment in COVID-19;HIV Infection and Immunosuppressive Disorders;2023-10-21

2. Antiviral strategies for epidemic and pandemic preparedness;Cell Host & Microbe;2023-06

3. Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort;Journal of Clinical Medicine;2023-01-21

4. Management of patients with lymphoma and COVID‐19: Narrative review and evidence‐based practical recommendations;Hematological Oncology;2022-10-25

5. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19;Annals of Internal Medicine;2022-10